Cellworks > Resources > Bibliography

Bibliography

AngioKit

2013

A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.
Authors

Wang, Z., et al.

Journal

Cell Death & Disease 4.9 (2013)

Inhibition of extracellular TG2 protein crosslinking or downregulation of TG2 leads to inhibition of angiogenesis in cell culture, using various models including V2a Kit: Vasculogenesis to Angiogenesis

2009

Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing.
Authors

Brcic, L., et al.

Journal

J Physiol Pharmacol 60.Suppl 7 (2009): 191-196.

2008

Induction of angiogenesis by airway smooth muscle from patients with asthma.
Authors

Simcock, David E., et al.

Journal

American Journal Of Respiratory And Critical Care Medicine 178.5 (2008): 460-468.

ASM cultured from subjects with mild/moderate asthma but not healthy controls promotes angiogenesis in vitro. The proangiogenic capacity of cell-conditioned medium samples was investigated using the AngioKit and quantified using image analysis

2007

Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma.
Authors

Simcock, David E., et al.

Journal

American Journal Of Respiratory And Critical Care Medicine 176.2 (2007): 146-153.

Bronchoalveolar lavage fluid collected from subjects with asthma but not healthy subjects is functionally active in promoting angiogenesis in vitro. The proangiogenic capacity of BALF samples was investigated using the in vitro AngioKit assay and analysed with the AngioSys software.

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.
Authors

Newman, S. P., et al.

Journal

British Journal Of Cancer 97.12 (2007): 1673-1682.

Demonstration that STX641 and STX140 have considerable potential for the treatment of hormone-independent breast and prostate cancer. The effect of the compounds on in vitro vessel formation was assessed using the Angiokit and analysed with the AngioSys software.

Call for papers

Cellworks would like to hear from all customers who have published using Cellworks products.

Please contact Caltag Medsystems office@caltagmedsystems.co.uk or telephone +44 (0)1280 827460 with the following details:

  • Researcher Name
  • Researcher Email
  • Article and Journal Title
  • Cellworks Product Used

Webmaster: AnnWebCom  |  Cellworks is a Caltag Medsystems company.  |  © 2012-2019 Caltag Medsystems Ltd. - all rights reserved  |  Privacy & Cookies